Physician profile
John C Perry
NPI 1952399073
$668.47
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2022: $138 · 2023: $215 · 2024: $53.35 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $228.83 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Ambu INC. | $118.89 | 2022 | |
| Edwards Lifesciences Corporation | $115.84 | 2023 | Hemosphere |
| Astrazeneca Pharmaceuticals Lp | $55.47 | 2019-2024 | Andexxa |
| Glaxosmithkline, LLC. | $31.32 | 2019 | |
| Mallinckrodt Enterprises LLC | $31.04 | 2019 | |
| Kerecis Limited | $24.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Getinge USA Sales, LLC | $19.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.41 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.